The following variables were significant predictors; age at scan, systolic blood pressure, heart rate, diabetes, hyperlipidemia, New York Heart Association (NYHA) class III or IV, use of angiotensin converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB), beta blocker, diuretics, digoxin, amiodarone, LVEDVI, LVESVI, LVEF, LV mass index, RVESVI, RVEF, indexed LA volume, any RVI site fibrosis, MWS fibrosis, and any LGE. This evidence concerns the gene ACE and hyperlipidemia.